RecruitingNot Applicable

Multiparametric SCores for Prediction of Myocardial fIbrosis in Patients With MITral vAlve pRolapse

Italy300 participantsStarted 2023-06-19

Plain-language summary

This is a multicenter, observational prospective and retrospective study which aims are: 1) to compute a scoring model potentially predictive for the diagnosis of fibrosis by CMR in patients with MVP; 2) to identify specific features that may predispose to ≥ mild VAs or SCD in patients with MVP.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * age ≥ 18 years * Echocardiographic diagnosis of mitral valve prolaspe, defined as a systolic displacement of one or both mitral leaflets ≥ 2 mm above the plane of the mitral valve annulus in long-axis views Exclusion Criteria: * age\< 18 years * coexistence of other cardiomyopathies or other ≥ moderate valve diseases * scarce acoustic transthoracic echocardiographic window * usual contraindications for cardiac magnetic resonance

What they're measuring

Prediction of fibrosis by CMR

Timeframe: June 2026

Trial details

NCT IDNCT06341166

SponsorCentro Cardiologico Monzino

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-06-19

Contact for this trial

Gianluca Pontone, MD

0258002574 gianluca.pontone@cardiologicomonzino.it

View on ClinicalTrials.gov More Mitral Valve Prolapse trials